Roberta Soffredini
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
HDV RNA Undetectability Rates During Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta May Be Assay Dependent.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 09, 2026
Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta☆.
Journal: JHEP reports : innovation in hepatology
Published: January 05, 2026
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV.
Journal: JHEP reports : innovation in hepatology
Published: April 23, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Journal: Hepatology (Baltimore, Md.)
Published: December 13, 2023
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Journal: Gut
Published: February 16, 2022
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR.
Journal: Journal of hepatology
Published: February 16, 2021
Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy.
Journal: The American journal of gastroenterology
Published: October 27, 2020
Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: April 08, 2020
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs.
Journal: Hepatology (Baltimore, Md.)
Published: March 19, 2020
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure.
Journal: Journal of hepatology
Published: February 28, 2019
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals.
Journal: Journal of viral hepatitis
Published: October 22, 2018
Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 08, 2018
Last Updated: 09/26/2026